title: Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo.
abstract: BACKGROUND
  The human coagulation trigger tissue factor (TF) is overexpressed in several types of cancer and involved in tumor growth, vascularization, and metastasis. To explore the role of TF in biological processes of lung adenocarcinoma, we used RNA interference (RNAi) technology to silence TF in a lung adenocarcinoma cell line A549 with high-level expression of TF and evaluate its antitumor effects in vitro and in vivo.
  
  
  METHODS
  The specific small interfering RNA (siRNA) designed for targeting human TF was transfected into A549 cells. The expression of TF was detected by reverse transcription-PCR and Western blot. Cell proliferation was measured by MTT and clonogenic assays. Cell apoptosis was assessed by flow cytometry. The metastatic potential of A549 cells was determined by wound healing, the mobility and Matrigel invasion assays. Expressions of PI3K/Akt, Erk1/2, VEGF and MMP-2/-9 in transfected cells were detected by Western blot. In vivo, the effect of TF-siRNA on the growth of A549 lung adenocarcinoma xenografts in nude mice was investigated.
  
  
  RESULTS
  TF -siRNA significantly reduced the expression of TF in the mRNA and protein levels. The down-regulation of TF in A549 cells resulted in the suppression of cell proliferation, invasion and metastasis and induced cell apoptosis in dose-dependent manner. Erk MAPK, PI3K/Akt pathways as well as VEGF and MMP-2/-9 expressions were inhibited in TF-siRNA transfected cells. Moreover, intratumoral injection of siRNA targeting TF suppressed the tumor growth of A549 cells in vivo model of lung adenocarcinoma.
  
  
  CONCLUSIONS
  Down-regulation of TF using siRNA could provide a potential approach for gene therapy against lung adenocarcinoma, and the antitumor effects may be associated with inhibition of Erk MAPK, PI3K/Akt pathways.
authors: Department of General Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
authors: Chengcheng
authors: C
authors: Xu
authors: Qi
authors: Q
authors: Gui
authors: Wenshu
authors: W
authors: Chen
authors: Leiming
authors: L
authors: Wu
authors: Wei
authors: W
authors: Sun
authors: Ni
authors: N
authors: Zhang
authors: Qinzi
authors: Q
authors: Xu
authors: Jianing
authors: J
authors: Wang
authors: Xiangning
authors: X
authors: Fu
references: Thromb Res. 2010 Apr;125 Suppl 2:S89-91
references: 20434015
references: Methods Mol Biol. 1994;32:9-15
references: 7951753
references: Cancer. 1992 Sep 1;70(5):1194-201
references: 1381270
references: Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):47-56
references: 15569823
references: Blood. 1983 Jul;62(1):14-31
references: 6407544
references: Am J Pathol. 2001 Jun;158(6):2031-41
references: 11395381
references: Chin Med J (Engl). 2006 Oct 20;119(20):1734-9
references: 17097022
references: Transplant Proc. 2005 Jan-Feb;37(1):233-6
references: 15808605
references: Nat Rev Cancer. 2002 Aug;2(8):563-72
references: 12154349
references: Nucleic Acids Res. 2002 Apr 15;30(8):1757-66
references: 11937629
references: Int J Cancer. 2005 Nov 1;117(2):294-9
references: 15900604
references: Int J Cancer. 2004 Dec 20;112(6):994-1002
references: 15386437
references: Clin Cancer Res. 2006 Jul 1;12(13):4055-61
references: 16818705
references: Adv Genet. 2005;54:117-42
references: 16096010
references: Lung Cancer. 2003 Sep;41(3):245-58
references: 12928116
references: Cancer Metastasis Rev. 2006 Mar;25(1):9-34
references: 16680569
references: Int J Hematol. 2001 Feb;73(2):145-50
references: 11372724
references: Nat Rev Cancer. 2007 Feb;7(2):79-94
references: 17251915
references: Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6922-6
references: 9192667
references: J Cancer Res Clin Oncol. 2010 Aug;136(8):1255-65
references: 20182889
references: Blood. 2008 Jan 1;111(1):190-9
references: 17901245
references: J Drug Target. 2008 Apr;16(3):185-97
references: 18365880
references: Mol Med. 2004 Jan-Jun;10(1-6):6-11
references: 15502877
references: Thromb Haemost. 1991 Jul 12;66(1):67-79
references: 1833852
references: J Pathol. 2008 Feb;214(3):283-93
references: 18095256
references: Best Pract Res Clin Haematol. 2009 Mar;22(1):61-9
references: 19285273
references: Cancer Res. 2003 Jun 1;63(11):2997-3000
references: 12782609
references: J Thorac Oncol. 2008 Jul;3(7):689-97
references: 18594312
references: Nat Rev Genet. 2007 Mar;8(3):173-84
references: 17304245
references: Science. 1997 Jan 31;275(5300):661-5
references: 9005851
references: Blood. 2005 Feb 15;105(4):1734-41
references: 15494427
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Int J Cancer. 1998 Feb 20;79(1):19-22
references: 9495352
references: J Thorac Oncol. 2010 Jun;5(6):825-9
references: 20421823
references: Physiol Rev. 1999 Jan;79(1):143-80
references: 9922370
references: Nat Med. 1996 Feb;2(2):167-8
references: 8574960